Literature DB >> 203941

Evidence for X-linkage of human phosphoribosylpyrophosphate synthetase.

R C Yen, W B Adams, C Lazar, M A Becker.   

Abstract

The mode of genetic transmission of human phosphoribosylpyrophosphate synthetase (ribosephosphate pyrophosphokinase; ATP:D-ribose-5-phosphate pyrophosphotransferase; EC 2.7.6.1) was studied in fibroblasts cultured from members of a family with a structurally and electrophoretically altered phosphoribosylpyrophosphate synthetase that has increased activity per enzyme molecule. Enzyme activity in fibroblast lysates from the daughter of an affected male patient was intermediate to the activities in lysates from her father (and her affected paternal uncle) and from her mother and other normal individuals. Two bands of enzyme activity corresponding to normal and mutant phosphoribosylpyrophosphate synthetases were found in fibroblast lysates from the daughter after cellulose acetate strip electrophoresis. In contrast, only mutant enzyme was detectable in lysates derived from the male patients. Fibroblasts cloned from the daughter contained two phenotypically distinct (normal and mutant) populations of cells with respect to phosphoribosylpyrophosphate synthetase activity and electrophoretic mobility. These studies support assignment of the structural gene for human phosphoribosylpyrophosphate synthetase to the X-chromosome. No evidence for the presence of the normal enzyme was found in erythrocyte or lymphocyte lysates or in partially purified erythrocyte enzyme preparations from the heterozygous daughter, suggesting either nonrandom X-chromosome inactivation in precursors of these cells or selection against hematopoietic cells bearing the normal enzyme after random X-chromosome inactivation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 203941      PMCID: PMC411274          DOI: 10.1073/pnas.75.1.482

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Human phosphoribosylpyrophosphate synthetase. Comparison of purified normal and mutant enzymes.

Authors:  M A Becker; P J Kostel; L J Meyer
Journal:  J Biol Chem       Date:  1975-09-10       Impact factor: 5.157

2.  X-linked pattern of inheritance of gout due to mutant feedback-resistant phosphoribosylpyrophosphate synthetase.

Authors:  E Zoref; A de Vries; O Sperling
Journal:  Adv Exp Med Biol       Date:  1977       Impact factor: 2.622

3.  Altered kinetic property of erythrocyte phosphoribosylpsyrophosphate synthetase in excessive purine production.

Authors:  O Sperling; P Boer; S Persky-Brosh; E Kanarek; A De Vries
Journal:  Rev Eur Etud Clin Biol       Date:  1972 Aug-Sep

4.  Accelerated erythrocyte 5-phosphoribosyl-1-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout.

Authors:  O Sperling; G Eilam; A De Vries
Journal:  Biochem Med       Date:  1972-08

5.  Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.

Authors:  M A Becker
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

6.  Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.

Authors:  E Zoref; A De Vries; O Sperling
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

7.  Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity.

Authors:  M A Becker; L J Meyer; A W Wood; J E Seegmiller
Journal:  Science       Date:  1973-03-16       Impact factor: 47.728

8.  Human phosphoribosylpyrophosphate synthetase: increased enzyme specific activity in a family with gout and excessive purine synthesis.

Authors:  M A Becker; P J Kostel; L J Meyer; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

9.  The rapid induction by phytohemagglutinin of increased alpha-aminoisobutyric acid uptake by lymphocytes.

Authors:  J Mendelsohn; A Skinner; S Kornfeld
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

10.  Phosphoribosylpyrophosphate synthetase is elevated in fibroblasts from patients with the Lesch-Nyhan syndrome.

Authors:  D W Martin; B A Maler
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

View more
  8 in total

Review 1.  Heberden oration 1979: human aberrations of purine metabolism and their significance for rheumatology.

Authors:  J E Seegmiller
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

Review 2.  A novel mutation in gene of PRPS1 in a young Chinese woman with X-linked gout: a case report and review of the literature.

Authors:  Bo-Yun Yang; Han-Xiao Yu; Jie Min; Xiao-Xiao Song
Journal:  Clin Rheumatol       Date:  2019-11-26       Impact factor: 2.980

3.  Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.

Authors:  Sheng Li; Yongcheng Lu; Baozhen Peng; Jianping Ding
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

4.  The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity.

Authors:  M A Becker; P R Smith; W Taylor; R Mustafi; R L Switzer
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

5.  Phosphoribosylpyrophosphate synthetase (PrsA) variants alter cellular pools of ribose 5-phosphate and influence thiamine synthesis in Salmonella enterica.

Authors:  Mark J Koenigsknecht; Luke A Fenlon; Diana M Downs
Journal:  Microbiology (Reading)       Date:  2009-12-03       Impact factor: 2.777

6.  Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions.

Authors:  M A Becker; K O Raivio; B Bakay; W B Adams; W L Nyhan
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

7.  Selective expression of phosphoribosylpyrophosphate synthetase superactivity in human lymphoblast lines.

Authors:  M J Losman; D Rimon; M Kim; M A Becker
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

8.  The mode of genetic transmission of gouty family with increased phosphoribosylpyrophosphate synthetase activity.

Authors:  F Takeuchi; F Hanaoka; E Yano; M Yamada; Y Horiuchi; I Akaoka
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.